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Pre-T cells that differentiate in thethymus into mature T cells are believed to arise
in the bone marrow, although the circulating form of the putative T cell precursor
has not been identified (1, 2) . The defining characteristic of a mature T cell is the
expression of an antigen-binding receptor (TCR), which is characteristically (ifnot
universally) associated with CD3 proteins . Themajority ofTcells in peripheral blood
express the cdo form of the TCR (TCR2), and a minority (1-3%) express they/S
chains (TCR-1) (3) . These receptors are encoded by genes that rearrange in T cell
precursors, with y chain rearrangement commonly occurring first . Although CD3
andtheTCR are known to be acquired in the thymus, the possibility of extrathymic
differentiation has not been excluded .
One of the earliest T lineage antigens, CD7 (gp40), is expressed before TCR-ß
gene rearrangement and surface expression ofCD1, CD2, andCD3 antigens and
persists on most mature circulatingTcells (4-6) . CD7 hasbeen demonstrated within
the bone marrow (1) and on fetal lymphocytes before colonization of the thymus
(4, 7) . Depletion of CD7+ cells from bone marrow results in the loss ofT cell
colony-forming capacity (2, 8) . Cells that are CD7+CD3 - (typically CD16+) are
known to exist in peripheral blood and display natural killer activity (9) .
These studies were designed to test the hypothesis that the circulating form of
theT cell precursor has a surface phenotype ofCD7+CD3- , and could be induced
to differentiate into CD3 + cells outside the thymus . We found that CD7 +CD3 - cells
purified and cloned from normal humanperipheral blood by FRCS differentiate into
CD3 + cells in the presence of IL-2, PHA, and irradiated feeder cells . These CD3+
cells include cells that are TCR1+ or TCR2+ and express various combinations
of other T cell surface antigens .
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Materials and Methods
Cell Preparation.
￿
Fresh peripheral venous blood (50-80 ml) from normal volunteers was
collected in acid citrate dextrose solution (Vacutainer; Becton Dickinson & Co., Mountain
View, CA) and mononuclear cells (PBL) were purified under sterile conditions by density
gradient centrifugation (1.077 g/cm3 Ficoll-Hypaque; Pharmacia Fine Chemicals, Piscataway,
NJ). Normal human thymus wasobtained from superfluous tissue removed atpediatriccardiac
surgery.
mAbs.
￿
FITC or phycoerythrin(PE)'-conjugated mAbs were obtained from Becton Dick-
inson &Co. : CDla (Leu-6), CD2 (Leu-5b), CD3 (Leu-4), CD4(Leu-3a), CD5 (Leu-1), CD7
(Leu-9), CD8a (Leu-2a), CD11b (Leu-15), CD16 (Leu-11), CD25 (anti-IL-2), CD45 (HLe-
1), CD57 (Leu-7), Leu-8, CD56 (Leu-19), CD71 (transferrin receptor), HLA-DR, TCR2-
ce//3 (WT31), and isotype controls (IgGl, IgG2a). The specificities of these reagents are de-
scribed elsewhere (10). WT31 showed little or no staining of TCRl ` cell lines at the con-
centrations utilized (11). mAbs that recognized constant epitopes of the TCR-1 chains were
obtained from T Cell Sciences, Inc. (Cambridge, MA), including TCR2 a chain (IdentiT
aFl), TCR-2 (3 chain (IdentiT OF1), TCR-1 7 chain (C-yMl), and TCRI S chain (IdentiT
TCR61). Anti-CD7 (RT7.1) (12) and anti-CD3 (RT3 .1)(10) mAbs were produced in ourlab-
oratory. Affinity-purified FITC-conjugated goat anti-mouse IgG (Tago Inc., Burlingame,
CA) was used as a second step for the unconjugated mAbs.
Staining.
￿
All staining steps contained PBS with 0.1% normal human serum (NHS) to
inhibit nonspecific binding. Cells washed in RPMI 1640/10% FCS were incubated in the
PE-conjugated reagent for 15 min on ice in the dark and the FITC-conjugated mAb was
added for an additional 30 min. For three-color staining, a third primary biotinylated re-
agent was added followed by streptavidin-APC (Becton Dickinson & Co.), or a monoclonal
reagent directly conjugated to the fluorochrome cyanine 5.18-OSu (13) (CY5 absorbtion
XMAX =652 nm, kindly provided by A. Waggoner, Carnegie Mellon University, Pittsburgh,
PA) for exitation by the Helium-Neon laser. Cells were washed twice in ice-cold PBS and
strictly kept in an ice bath before and during the sorting procedure to prevent modulation
or shedding ofthelabeled antigens (10). Cellstaken from tissue culturefor surfacephenotype
analysis were washed free of tissue culture media, fixed in 1% paraformaldehyde/PBS for
10 min, and resuspended in 4°C PBS.
For IdentiT aFl, /3F1 and C7MI staining, cells were air dried on Histostick (Accurate
Chemical & Scientific Corp., Westbury, NY)-treated glass slides for 1 h, fixed in acetone for
10 min, and air dried for 10 min. After 15 min of incubation with 1:50 normal goat serum,
primary antibodies were applied for 1 h at 22°C, followed by three washes. FITC-labeled
goat anti-mouse IgG was applied for 30 min, followed by three washes. Slides were cover-
slipped and read on a fluorescence microscope (Carl Zeiss, Inc., Thornwood, NY).
Sorting/Cloning.
￿
Cell sorting and analysis was performed on a five-parameter FACS440
cell sorter (BectonDickinson & Co.) equipped with a 5-W argonlaser(Innova90; Coherent
Inc., Palo Alto, CA)tunedto 488 nm at 200mW of power. Three-color immunofluorescence
was performed with an additional 47 mW Helium-Neon laser(model 107A; Spectra-Physics
Inc., Mountain View, CA) at 633 nm, intercepting the sample stream 254 Jim below the
argon laser. Fluorescence emissions were collected by selective bandpass filtration of FITC
(530 ± 15 nm), PE (575 t 12 .5 nm), propidium iodide (PI) (630 t 10 nm), and al-
lophycocyanin (APC) or CY5 (660 ± 10 nm) signals. The overlap of FITC and PE fluores-
cence emissions were correctedby an electronic compensation network; APC or CY-5 emis-
sionswere both spectrally and temporally distinct from lower wavelength emissions. To omit
cell clumps and doublets, unwanted dead cells, and debris from the sorted population, for-
ward vs. right scatter gating and forward angle thresholding at low sorting rates (<1-2 x
103 cells/s) were utilized, as described (14).
Upon completion of sorts, 5-10 x 103 cells from purified populations were immediately
analyzed with "open" forward vs. side scatter gates (ungated), forward angle thresholdjust
' Abbreviations used in this paper: APC, allophycocyanin; ET cells, extrathymic T cells; NHS, normal
human serum; NT cells, natural T cells; PE, phycoerythrin; PI, propidium iodide.PREFFER
ET AL
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above
electronic noise, and live cell gating with PI through the fifth parameter channel of
the
cell sorter to determine the final purity of the sorted cells
.
This stringency was imposed
because
preliminary experiments showed that sorted CD7'CD3- populations could appear
to
be >99
.99%
pure if scatter gated, but still contain a few presumptive contaminating cells
just
outside the defined lymphocyte scatter gate
.
Data acquisition, reprocessing, and display
were
performed on Hewlett-Packard 217 and 310 computer systems running CONSORT 30
or
LYSYS analysis software (Becton Dickinson & Co
.).
Cell
Culture
.
￿
Cultures
ofcells sorted to >99
.99%
purity were initiated with a 10-fold excess
(-106)
of autologous x-irradiated (3,000 rad) feeders and optimal mitogenic concentrations
(1-214g/ml)
ofPHA (Leukoagglutinin
;
Pharmacia Fine Chemicals) within the wellsof 48-well
culture
plates
.
All cultures were grown at 37'C in 5% C02 in RPMI 1640 with L-glutamine
supplemented
with 10% FCS, Hepes (2
.4
gm/liter), nonessential amino acids (1 MM/liter),
sodium
pyruvate (1 mM/liter), gentamicin (0
.1
mg/ml) and 1,000 U/ml rIL-2 (Cetus Corp
.,
Emeryville,
CA)
.
Control wells containing only feeder cells were established at the initiation
of
all cell cultures and restimulations (in all 24-, 48-, or 96-well plates) to exclude growth
of
feeder cells as a source ofcell contamination
.
Cell cultures were subsequently restimulated
with
PHA and auto- or allogeneic irradiated feeder cells approximately every 3 wk to main-
tain
cell growth
.
Cells sorted to >99
.99%
purity were also cloned with a single cell deposi-
tion
unit (Becton Dickinson & Co
.)
(1 cell/well) into 96-well tissue culture plates containing
2
x 105 autologous feeders/well and PHA as above
.
HLA serotyping was performed by stan-
dard
techniques
.
Antigen
Modulation
.
￿
Freshly
isolated PBL from three separate donors were stained with
direct
antibody conjugates for CD7 (Leu-9) and CD3 (Leu-4)
.
Aliquots from each donor
were
immediately fixed in 1 % paraformaldehyde or maintained in the dark on ice or at room
temperature
for 1, 2, or 3 h
.
CD3-induced
Proliferation
.
￿
Freshly
sorted CD7'CD3- and CD7'CD3' cells were plated in
triplicate
(5 x 104/well) with irradiated autologous feeder cells (2 x 105/well)
.
Irradiated cells
alone
served as negative controls
.
A mitogenic concentration (0
.5
hg/ml) of anti-CD3 mAb
RT3.1
was added to each well
.
Proliferation was assessed after 48 h of culture at 37°C in
5%
C02 by incorporation of ['H]thymidine (1 uCi/well) during a 4-h exposure
.
Statistical
Analysis
.
￿
All
data are given as means ± SD
;
p values are calculated by paired
student's
t test
.
In the cloning experiments the probability that the observed number ofCD3'
clones
was due to chance contamination by natural T (NT) cells was calculated from the
Poisson
formula (15)
:
f(n) = [(Np)' (1-p)°]/n!
;
where N = the number of seeded wells, n
=
the number of positive wells, and p = the frequency of positive cells in original material,
corrected
for the measured plating efficiency of the NT cells, which varied from 6 to 32%
.
For
the purposes ofthis calculation the potential contamination was assumed to be one order
of
magnitude more (0
.1%)
than actually measured (<0
.01%).
Results
CD7+CD3-
Cells in Peripheral Blood
.
￿
In
normal blood 13
.1
t 6
.857o
(n = 9) of
the
lymphocytes were CD7+CD3- (Fig
.
1 A)
.
The separation between C133- and
CD3'
cells in the blood was quite distinct, in contrast to the thymus, which had
an
intermediate CD3DIM' population (Fig
.
1 D)
.
The blood CD7'CD3- cells had
significantly
more intense staining for CD7 than the CD7'CD3' cells over the iden-
tical
forward scatter range (528 t 250 vs
.
350 ± 161 mean fluorescence intensity
units,
p = 0
.02;
Fig
.
1 A)
.
The
expression of selected cell surface antigens on CD7'CD3- cells is compared
with
CD7'CD3' cells in Fig
.
2
.
By three-color FAGS analysis, CD7'CD3- cells
were
uniformly CD45' and CD11b', but expressed no detectable CDl, CD4, CD5,
CD10,
CD13, CD14, CD25, HLA-DR, CD71, TCR1, or TCR-2
.
The CD7'CD3-
cells
were heterogenous in their expression ofCD2, CD8, CD16, CD56, CD57, and
Leu-8 .
Four subpopulations were evident in freshly sorted CD7'CD3- cells (Fig
.TCR1
A
CD3
B
FIGURE 1.
￿
Pre- (A) and post-
sort two-color flow cytometric
analysis of fresh PBL from
donor G stained with anti-
CD7 (Leu-9 FITC) and anti-
CD3(Leu-4 PE). Post-sort anal-
ysis of CD7*CD3- (B) and
CD7'CD3' (C)cells. Cells de-
rived from a 6-mo-old infant
and are seen in D. Cells were
stained, sorted, and analyzed
as described in Materials and
Methods. The results are plot-
ted by logfluorescence intensity
as contours that enclose 1, 3, 10,
and 30 cells.
FIGURE 2.
￿
Triple-color flow cytometric analysis of freshperipheral blood
stained with anti-CD7 (Leu-9 FITC) and anti-CD3 (Leu-4 APC) mAbs
(top)comparingtheexpression of a thirdantigen (usually PE conjugate)
on either the CD7'CD3- (left) or CD7*CD3* (right) population. Leu-7
(CD57),WT31, andTCR-Sl areFITC conjugates combined with RT7.1
APC and Leu-4 PE. CD2 was directly conjugated to CY5.CD2
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FIGURE 3.
￿
Expression of CD2 and CD8 on CD7'CD3- cells.
Fresh peripheral blood was stained with anti-CD7 (Leu-9 FITC)
and anti-CD3 (Leu-4 PE)and sorted on the FACS440. Freshly
sorted CD7'CD3 - (only FITC') cells were immediately re-
stained with anti-CD2 (Leu-5b CY5) and CD8 (Leu-2 PE).
3): CD2+CD8- (51 ± 8%), CD2+CD8DIM+ (18 t 4%), CD2-CD8- cells (24 t
4%), and CD2-CD8DIM+ (7 t 3%) (data from three donors).
Differentiation of CD7+CD3- Cells in Culture.
￿
Recovery of CD7+CD3- cells to
>99.99% purity was usually achieved by two sorting cycles on the FACS440, with
an average yield of 2.9 x 105 CD7+CD3- cells (Fig. 1 B; Table I). CD7+CD3- cells
were initially cultured in rIL-2 (1,000 U/ml), PHA, and autologous irradiated PBL
feeder cells. As a control, CD7+CD3+ cells were sorted simultaneously and cultured
under the same conditions (Fig. 1 C); these CD7+CD3+ culture cells were termed
NT cells.
CD7+CD3- cells in culture were periodically monitored for the presence of CD3
and othercell surfaceantigens. Analysis ofallcultures was dependentupon cell growth
(which couldbe variable) and not a sequential monitoring schedule. After alagperiod
in which no CD3 could be detected, eight of nine separate cultures of CD7+ CD3-
cells began to display CD3 on an increasing fraction of the cells (Fig. 4). In an av-
TABLE I
Acquisition of Surface CD3 by CD7+ CD3- Blood Pre-T Cells In Vitro
* All cells cultured were sorted to >99.99% final purity .
l Data represent days in culture after initial CD7'CD3- purification.
S CD3 was not detected during 90 d of culture.
II 40% of the cells were CD3' at day 48.
Mean.
** SD.
t 7
_ cbJ Sa..
Exp. Donor
Initial percent
CD7'CD3-
Sort
cycles* Yield
Dayl
>5%
CD3'
>90% TCR
X10-3
1 A 4.2 2 372 60 88 TCR-1
2 B 10.6 2 500 34 50 TCR-l + -2
3 C 9.8 2 300 14 107 TCR-2
4 D 16.4 3 80 38 105 TCR-1
5 E 5.6 4 ND 63 135 TCR-2
6 F 26.2 2 600 49 64 TCR-2
7 G 21 .8 2 255 _5 -4
8 G 12.8 2 196 37 -11 TCR-1
9 H 10.1 2 80 21 44 TCR-1 + -2
13.11 298 40 85
6.8** 175 16 31182
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erage of 40 ± 16 d (range, 14-63 d) at least 5°jo of the cells were CD3 + , and by
an average of 85 ± 31 d (range, 64-135 d) >90ojo of the cells were CD3+ (Table I) .
Once CD3+ was expressed, the CD3 + cells gradually predominated, and the cul-
ture usually became >90 1 /c CD3+ in 2-3 wk (Fig. 4) . The rate ofCD3 + acquisition
did not correlate with the percentage of CD7 +CD3 - cells in the blood of the donor.
CD7+CD3 - cells that acquired CD3+ in culture are hereafter referred to as ex-
trathymic T (ET) cells .
In five experiments (1, 2, 4, 8, and 9), the ET cells expressed TCR-1, and in five
(2, 3, 5, 6, and 9), they expressedTCR2 (Tables I and II) . Both TCR-1 + andTCR
TABLE II
Cell Surface Antigens Expressed on ET andNT Cells
FIGURE 4 .
￿
Time course ofthe appearance
ofCD3 in CD7*CD3 - cultures.
d, dim stain ; b, bright stain ; scored + if >10% of cells were positive . Each distinct ET phenotype in the
bulk culture is listed . TCR-1 reagents are TCR-61 and CyMl ; TCR-2 reagents are ßF1 and WT31 .
Exp . Donor Cells CD2 CD3 TCR-1 TCR-2 CD4 CD5 CD7 CD8 CDllb CD16 CD56
1 A NT + + - + + +b + +b +
ET + + + - - - + +d +
2 B NT + + - + - +b + +b
ET + + + - + +d + -
ET + + + - - +d + -
ET + + - + - +b + +b
3 C NT + + - + + +b + +b
ET + + - + - +b + +b
4 D NT + + - + - +b + +b
ET + + + - - +d + -
5 E NT + + - + + +b . + +b
ET + + - + - +d + +b
6 F NT + + - + + +b + +b - + +
ET + + - + + +b + - - - -
ET + + - + + +d + - - - -
7 G NT + + - + +b + +b
ET + - - - - + +d
8 G NT + + - + - +b + +b
ET + + + - - +d + - +
9 H NT + + - + - +d + +b +
ET + + + - - +d + - - - +
ET + + - + - +b + +b - - +PREFFER ET AL.
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2+ cells were detected in experiments 2 and 9. Cultures of CD7+CD3- cells from
all donors tested became CD3 + , although in one of two experiments with donor G
(experiment 7, Table I), CD7+CD3- cells were maintained for 90 d with no evi-
dence of transition to CD3+ ; these cells remained CD7+CD3- , CD2 + , CD5- ,
CD8DIM+, and TCR- . In another experiment (not shown) donor A CD7 +CD3 -
cells were CD3+ when first examined on day 14. Since the time course was atypical
(no lag period was demonstrated) and both the NT and ET cells were TCR2+
CD8+, CD3 + contamination could not be excluded.
The extended phenotypes of the ET and NT cells are given in Table II. All ET
and NT cultures expressed CD45, CD2, and CD7 . The ET TCR1+ cells were
CD5D1M+ (5/6), CD4-CD8 - (4/6), CD4-CD8DIM+ (1/6), or CD4 +CD8 - (1/6) (Figs.
5 and 6). The ET TCR-2 + cells expressed either CD5BRIGHT+ (4/6) or CD5D1M+
(2/6) and were CD4-CD8+ (4/6) or CD4+ CD8- (2/6). ET cultures in experiments
2 and 9 consisted of TCR1+ cells that were CD8 - and TCR-2+ cells that were
CD8+ . CD16, CD11b, and CD56, present on the starting population of CD7+CD3 -
cells, were sometimes detected on ET TCR-1+ and TCR-2+ cells.
The NT cells, tested at a time when the corresponding ET culture became CD3+,
were all CD5+ (9/9); four NT cultures were >90% CD8 +CD4-, while the remaining
four were mixtures of CD4+CD8- and CD4-CD8+ cells (one was not tested for
CD4). CD16, CD11b, and CD56 were variably present. The CD7+CD3+ NT cells
remained CD3 + in association with TCR-2 + ;- no detectable outgrowth of TCR-1 +
cells was detected over the same time periods ET cells were cultured.
Controls.
￿
In every experiment the ET cells differed from the NT established at
the same time from the same donor by the presence or degree of expression of one
to six surface molecules (TCR, CD4, CD8, CD5, CD7, CD11b, or CD56; Table
II; Figs. 5 and 6). Wells containing irradiated feeder cells alone plus PHA and IL-2
were established to monitor their potential for growth; no cells grew from these cul-
tures. To monitor for contamination with allogeneic feeder cells or other cells, four
donors and their ET and NT cells were HLA typed. The HLA type of each ET
and NT cell line tested was the same as the corresponding donor (data not shown).
The possibility of antigenic modulation ofCD3 before or during sorting was tested
by monitoring the change in CD3 intensity after staining under conditions equiva-
lent to or less stringent than the sorting procedure. No antigenic modulation of CD3
could be demonstrated on cells maintained on ice for up to 3 h, as measured by
mean fluorescence intensity after 3 h (293 ± 19 U), compared with the controls
fixed immediately after staining (294 ± 25 U). Cells maintained at room tempera-
ture for 3 h had only a slight (<5%) and nonsignificant decrease in binding com-
pared with the controls; no change in the percentage of positive CD7 +CD3+ cells
was detectable (data not shown). The expression of CD7 on CD7+CD3- cells was
stable over a 3 h period, either on ice or at room temperature. However, an appreciable
reduction of staining intensity of CD7 did occur on CD7+CD3+ cells after 2-3 h
at room temperature (30 ± 0.1 U) compared with controls (46 f 5.8 U; p < 0.001).
Addition of anti-CD3 (RT3.1) caused no increase in [3H]thymidine incorporation
in freshly sorted CD7 +CD3 - cells cocultured with irradiated feeders, compared with
feeders alone (data not shown).
Cloning of CD7+CD3" Cells.
￿
The main purpose of the cloning experiments was
to determine whether the ET cells might simply represent outgrowth of residual184
￿
EXTRATHYMIC DIFFERENTIATION OF HUMAN BLOOD PRET CELLS
N
U
U
h
~o
0
U
A
C
TCR2
CD5
N
D
U
z U F-
4- 1,
e
FIGURE 5. Comparative ex-
pression ofcell surfaceantigens
on cultured NT vs. ET cells
after 48 d in culture (experi-
ment 8). Subpopulations ofcells
sorted as CD7+CD3- (ET
cells; A and C are TCR-1+ and
CD2+, whileallcells in the cul-
ture are CD4- and CD8-.
CD7+CD3+ cells (NT cells;
B and D) purified from the
same experiment are all CD2+,
CD4-, CD8+ . All NT cells are
TCR-2+ and bright CD5+ (E
andF, dark histograms), whereas
the ET cells are TCR-2- and
CD5- or CD5°tM+ (E and F,
clear histograms). Multiparamet-
ric fluorescence analysis of the
ET cells indicates that in ad-
dition to CD4-, CD8-, the
TCR1+ cells are CD3+, CD16-
(G), and CD2+ (H). The re-
mainingCD3- cells in thecul-
ture retain CD16+ found on
circulating CD7+CD3- cells,
and are predominantly CD2+ .
mature T cells. In five experiments, aliquots of the CD7+CD3- from the final
purification step were cloned by the FACS440 (1 cell/well) into 96-well plates, under
the culture conditions described. Cell growth was detected in 20 instances (of 1,440
wells seeded); sufficient numbers of cells were available for cell surface analysis in
H
f
O
GCD4
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FIGURE 6.
￿
Expression ofCD4on ET TCR1' cells. ET cells from
experiment 2 were stained with antiTCR1 (TCRSl FITC) and
anti-CD4 (Leu-4 PE). All TCRl' cells are WT31-, CD8-,
CD5DIM, (not shown), while a subpopulation of TCR-1' cells
coexpress CD4.
14/20 wells. 10 ofthese 14 clones (71%) expressed CD3; one was 8% CD3+ but was
lost in culture before it could be retested, and 3/14 remained CD3-. Most (9/10)
CD3+ clones tested were TCR2+, and either CD4+ or CD8+. One well from ex-
periment 8 grewout both TCRl' and TCR-2' cells (in this experiment cell growth
was observed in 1/288 wells); the TCR2+ cells were CD4-CD8+ and the TCR-1+
cells were CD4-CD8- or CD4+CD8-. Both TCR-1+ and TCR2+ cells were
CD5DIM,, as were the ET cells from the same experiment (Fig. 5 F); in contrast,
the corresponding NT cells were CD5BRIGHT+, In control plates seeded with
CD7+CD3+ cells, growth was observed in 132/480 (28%) wells; all that were tested
were CD3+, TCR-2+.
In three experiments with different donors (A, G, and H), data were obtained
that permit a calculation ofthe probability of contamination. In these experiments,
8/288, 1/288, and 1/288 wells seeded with CD7+CD3- cells were CD3+ (one well
was CD3-). In the same experiments, wells seeded with CD7+CD3+ cells grew in
31/96, 29/96, and 6/96 wells, respectively (all tested were CD3+). The probability
(Poisson) that the CD3+ cells in the CD7+CD3" wells were due to chance contami-
nation with a CD7+CD3+ cell is <10-12, <0.01, and <0.002 in the three individual
experiments, respectively.
Discussion
This report identifies a hitherto unknown class ofT cell precursors that circulate
in normal peripheral blood. Highly purified (>99.99%) CD7+CD3- preT cells from
all normal adults tested were capable ofextrathymic differentiation into CD7+CD3+
cells when cultured in the presence of IL-2, PHA, and irradiated feeder cells. In
bulk culture the ET cells were predominantly TCR-1+, despite the much higher fre-
quency ofTCR2+ cells in normal blood. Purified CD7+CD3- cells developed the
capacity to express CD3 in association with either TCR1 or TCR-2, and expressed
other mature Tcell surface antigens, including CD4, which was generally absent
on CD7+CD3- cells. The TCR1' cells grown from these cultures were CD4-CD8-,
CD4-CD8DIM+, and CD4+CD8-, while TCR2' cells were CD4+ or CD8+. The
TCR-1+ CD4+ phenotype has not been previously described, possibly because se-
lection techniques utilized eliminated CD4+ cells (16-18).
Alternative explanations for the results described here were excluded by several
observations. The CD7+CD3- cells were sorted two to four times to give apopula-186
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tion that was >99.99% pure, even with no gating on the lymphocyte scatter gate.
Mature T cells grown under the same conditions from the same donor always had
a phenotype that differed by one or more markers from the ET cells. Artifactual
conversion ofCD3' to CD3- cells due to modulation before sorting was not demon-
strable undertheconditionsofstainingandsorting. Anti-CD3 didnot induce prolifer-
ation ofsorted CD7+CD3- cells after 2 d ofculture. In addition, the lag period of
-40 d before 5% of the cells became CD3+ could not be explained by simply
recovery ofmodulated cells. The generation of TCRl' cells from the majority of
the CD7+CD3' bulk cultures adds strong additional evidence, since TCR1' cells
are a small fraction (<3%) of circulating T cells. The rare (CD5DIM+) and novel
(TCRl' CD4') cell phenotypes observed in ET cells also argue against contami-
nation by NT cells. Finally, differentiation ofCD7'CD3- into either TCR2' CD3'
or TCRl' CD3+ cells was detected at a clonal level in three experiments with a
frequency that was extremely unlikely to be due to chance contamination by CD3'.
The lack of growth of feeder cells alone and the HLA typing of donors and their
long-term cultured cell lines ruled out the possibility of contamination by feeder
or unrelated cells.
The present results support prior observations that extrathymic fetal tissues con-
tain CD7'CD3- T cell precursors that differentiate into CD3+ T cells in the pres-
ence of IL-2 (4, 18-20). A committed CD7'CD3- T cell precursor has been
identified in human fetal liver and yolk sac in the seventh week of gestation and
soon thereafter in the thymic rudiment (4). Cells cultured from these fetal organs
inthe presence ofIL-2 express mature T cell surfaceantigens invitro (4). Intrathymic
"prothymocytes" (CDl-CD2-CD3-CD4-CD7'CD8-) have also been reported to
differentiate into CD3' TCR-l' or TCR2' populations in vitro (18). In the latter
experiment prothymocytes were obtained by complement mediated lysis, and "ma-
tured" with IL-2 stimulation after 8 d of culture. This purification technique does
not providethe purity ofcell sorting, and hence, minorcontamination (1%) isdifficult
to exclude. However, the shorter time for appearance of CD3' cells among culture
thymic CD3- cells would be consistent with an enhanced capacity to grow and
differentiate compared with pre-T cells in the blood.
Sequential acquisition of surface differentiation antigens has been described in
thenormal thymus (21), and in culturesofprothymocytesinvitro(18). CD2is reported
to be the first Tcell antigen acquired by immature CD7' thymocytes after coloni-
zation ofthe thymic rudiment, precedingCD3 expression (4). Preliminary evidence
suggests that blood CD2-CD7'CD3- cells may recapitulate the intrathymic matu-
ration scheme by acquiring CD2 before CD3 (Preffer et al., unpublished results).
Two differences in the ET pathway compared with the intrathymic pathway were
the absence ofdetectable CD1 expression and the lack of intermediates with both
CD4 and CD8. Furthermore, most ET cells expressed less CD5 (CD5- or CD5DIM')
than NT cells (CD5BRIGHT+) a phenotype shared with early thymocytes.
The optimum or essential conditions for the observed differentiation of ET cells
was not determined, although IL-2 in combination with PHA and feeder cells was
sufficient. High concentrations (>10U/ml)ofIL-2 may be required, as preliminary
experiments with reduced levels ofIL-2 failed to produce outgrowth ofCD3' cells.
In a prior study, CD3' cells were not detected after CD3- peripheral blood cellsPREFFER ET AL.
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were cultured in IL-2 for 44 wk. (9). The failure to detect CD3+ cells may have
been relatedto thelimited interval ofobservation, or culture conditions (lackofPHA
stimulation or feeder cell population). PHAstimulates production of aTcell differen-
tiating factor from bone marrow cells depleted of T cells (22). The ET TCR1+ cells
displayed a low efficiency of cloning (1/10 wells), compared with TCR-2+ cells. The
reason forthe difference maybe related to cultureconditions, such as arequirement
for as yet unidentified cell types or growth factor(s). It is notable that the culture
conditions to generate ET cells (high dose IL-2)aresimilar to those used to generate
lymphokine activated killer cells (23).
The CD7 molecule is a member of the Ig gene superfamily (24). An infant with
a severe combined immunodeficiency and few circulating CD3+ cells lacked expres-
sion of CD7, arguing that CD7 is necessary for the normal maturation of T cells
(25) . However, in vitro studies have not yet clearly identified a functional role of
CD7. Antibodies (e-g., RT7.1) that modulate CD7 inhibit primary MLRs, but do
not inhibit effector T cells or stimulatemitogenesis(26). As notedhere, CD7 modu-
lates more readily on CD3+ cells than CD3- cells, which may be due to intrinsic
differences in the cells or to perturbation of CD3. A substantial fraction of T cells
derived from rejecting human renal allografts (12) and a subset of mature CD4'
cells (27) lack CD7. The presence of CD7 in pre-T cells, and its decreased density
on mature T cells, are consistent with the hypothesis that CD7 plays a critical role
in homing to the thymus or in early ontogenetic events.
The actual frequency of T cell precursors in the blood was not directly demon-
strated by these studies. Although the CD7+CD3- cells comprised 13% of the cir-
culating blood lymphocytes, not every cell with this phenotype necessarily has the
ability to differentiate into aTcell. Based on the cloning data, the Tcell precursors
capable of productive extrathymic differentiation under these conditions are -5%
of CD7+CD3- cells (assuming a plating efficiency equal to T cells in the same ex-
periment), or -0.7% of circulating lymphocytes.
A question arises as to whether the demonstrated ET pathway has any in vivo
significance. Many studieshave documented thepresence of mature T lymphocytes
in athymicmice, albeit at levels far belownormal (28). These mice lack thymic epi-
thelial cells, although their bone marrow T cell precursors are normal (29). T cells
are not demonstrable at birth, but increase with age in the spleen and lymph nodes
to detectable levels (30). ThesplenicT cells from athymic mice are unusualin having
increased TCR-1 mRNA (31, 32), a several-fold increase in the proportion of
CD4-CD8- T cells, and a reduced (<10%) capacity to proliferate in response to
mitogens (30, 33). The TCR/3 gene rearrangements studied show limited diversity
(28, 34). Together these data suggest the TCR-1 pathway is less dependent on in-
trathymicmaturation than the TCR2 pathway. In supportof this view, extrathymic
TCR-y gene rearrangement can be detected in the fetal mouse liver before thymic
colonization (35), and patients whohave received Tcell-depleted bone marrow some-
times have increased levels of TCR-1' cells in the circulation (36). These data are
in accord with our observation that populations of CD7+CD3- cells mature ex-
trathymically into TCR1` cells more frequently than expected from their rarity in
the blood. The ET pathway may contribute proportionally more cells in vivo if the
thymusis inactive or absent (e.g., agingor thymectomy), or ifthe stimuli fordifferen-188
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tiation are increased. It is not inconceivable that the increased frequency of TCR
1+ cells isolated from sites of chronic autoimmune inflammation may be due to their
derivation from the ET pathway (37, 38).
Our data do not address whether ET cells have previously been "educated" in the
thymus or whether the TCR genes have begun rearrangement in vivo. Circulating
CD7+CD3 -CD2 - lymphocytes might be unexposed to the thymic microenviron-
ment, exposed but refractory to thymic processing, or partially processed by some
alternative mechanism . In any case, the precursors of ET cells lack any detectable
surface TCR that would permit thymic education by self-MHC antigen recognition
(selection). Such T cells that mature under extrathymic conditions may have un-
usual, even "forbidden" specificities.
Summary
CD7+CD3- cells purified (>99.99%) by FAGS from the peripheral blood of
healthy adults include precursorsfor mature T cellsthat have the capacity to differen-
tiate into TCRl+ or TCR 2+ CD3 + cells. Extrathymic differentiation was demon-
strable from all eight healthy donors in the presence of a high concentration of IL-2,
mitogenic levels of PHA, and irradiated blood mononuclear feeder cells, after a lag
of -40 d in vitro. The extrathymic T (ET) cells were predominantly TCR1+, al-
though TCR2+ cells were also derived. ET TCR-l+ cells were CD4-CD8- ,
CD4- CD8DIM+ , and CD4+CD8- , and were distinguished from natural T TCR2+
cells by a variety of cell surface markers. The ET cells had phenotypes generally
displayed by normal mature T cells, although the CD5DIM+ on ET cells was more
typical of thymocytes. Acquisition of CD3 on purified CD7+CD3 - cells was not due
to antigenic modulation or growth of contaminants, and ET cells could be demon-
strated at the clonal level. Studies in athymic mice and bone marrow recipients support
the view that extrathymic maturation does occur in vivo. Whether the CD7+CD3-
cell population was unexposed to the thymus, or exposed but not processed, is un-
known. In any case, unusual or "forbidden" autoreactive specificities are predicted
since ET cells differentiate without thymic selection of the TCR.
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